3rd Quarter - Report
FIERCE GOVERNMENT RELATIONS for MOMENTA PHARMACEUTICALS, INC.
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Risk Evaluation Mitigation Strategies, industry user fees, S.934 - FDA Reauthorization Act of 2017, H.R. 2430-FDA Reauthorization Act of 2017, H.R. 2212-CREATES Act of 2017, S. 974-CREATES Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM KIRK BLALOCK | — |
| KIRSTEN CHADWICK | — |
| MICHAEL CHAPPELL | — |
| KATE HULL | — |
| ALEIX JARVIS | — |
| DANIELLE MAURER | — |
| WILLIAM PIPER | — |
| TYLER STEPHENS | — |
| ERIC ZULKOSKY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.